Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Automating Tobacco Cessation in Primary Care

Official title: Automating Tobacco Cessation in Primary Care Via EHR Integration: A Non-Randomized Trial

Run by University of Pennsylvania · NCT07735286 · Data updated 2026-11-12

This project tests a workflow in primary care to identify smokers and help them access nicotine replacement therapy (NRT) during routine visits.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment4800 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedSeptember 24, 2026
Main results expectedMarch 23, 2027
Study endsAugust 1, 2027
Registry record updatedOctober 21, 2026
Trial IDNCT07735286 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older who smoke and receive care at Penn Family Care or Edward Cooper Internal Medicine and meet the visit and prescription criteria outlined in the inclusion rules.

Probably not a fit

Patients who do not use or obtain nicotine replacement therapy or those not engaged with the healthcare workflow may see no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention aims to streamline how primary care teams identify patients who smoke and present tobacco treatment options, including NRT such as patches, gum, or lozenges. It will implement a workflow at Penn Family Care with Edward Cooper Internal Medicine serving as a comparison site. A 30-day follow-up survey will collect data on whether patients received, picked up, or used NRT, and any barriers experienced. The study will focus on patients aged 18 and older who are active smokers and have had eligible visits, comparing those who receive the intervention to standard care. Primary analysis uses electronic health record data to identify active smokers and exclude those who recently had an NRT prescription.

Why it matters

Potential benefit: If successful, the workflow could increase the rate at which primary care teams offer and patients receive nicotine replacement therapy, potentially aiding more patients in reducing or quitting smoking.

How similar studies have gone: Prior work supports using structured workflows to improve smoking-cessation discussions and NRT uptake, though the specific automated workflow in primary care is being evaluated here.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Patient at Penn Family Care or Edward Cooper Internal Medicine
* Had an eligible scheduled or completed practice visit categorized as a new annual visit, return patient visit, return annual visit, or return patient sick visit
* For the tobacco cessation intervention: Penn Family Care patient who had not previously completed the tobacco questionnaire
* For the 30-day follow-up survey: Active smoker in the EHR as of the completed visit date or prescribed nicotine replacement therapy (NRT) between 3 days before and 30 days after the completed visit date
* For the primary analysis: Active smoker in the EHR as of the completed visit date
* For the primary analysis: Did not have an NRT prescription between 34 and 4 days before the completed visit date

Exclusion Criteria:

* None except as specified in inclusion criteria.

Where it's running

  • Penn Medicine
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Text2Quit-Kenya: a mobile message program to help ED patients quit tobacco

    Researchers will test a text message-based smoking-cessation program with Kenyan emergency department patients to see if it helps people quit and learn what works in this setting.

    Recruiting Yale University · Nairobi · NCT07734727

  • Extended tobacco support for people experiencing homelessness

    This program tests whether extending tobacco treatment to 6 months with pharmacist counseling, monthly nicotine replacement deliveries, and phone wellness coaching helps adults experiencing homelessness quit smoking compared with a 3-month package.

    Recruiting Phase 4 University of California, San Francisco · San Francisco, California · NCT07148232

  • Improving tobacco cessation support for patients in poverty in Utah

    This study is testing new ways to help people living in poverty in Utah quit smoking by using support tools and strategies in their healthcare clinics.

    Recruiting University of Utah · Salt Lake City, Utah · NCT06881069

  • Helping pregnant women quit smoking with community health workers

    This study is testing a new program that uses community health workers to help pregnant women in San Bernardino County quit smoking by providing support through home visits.

    Recruiting Loma Linda University · Loma Linda, California and 1 other locations · NCT06438549

  • Using Cannabidiol to Help People Quit Smoking

    This study is testing if taking cannabidiol (CBD) can help people who smoke more than 10 cigarettes a day quit smoking and feel better during withdrawal.

    Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT05445804

  • One extra structured CBT session to help cancer patients quit smoking

    This trial tests whether adding one CBT-based smoking-cessation session to standard brief counseling helps cancer patients quit smoking cigarettes.

    Recruiting Vietnam National Cancer Hospital · Hanoi · NCT07822464

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.